Pet health manufacturer Beaphar, strengthened its sales support offering for retailers following the reclassification of its FIPROtec combo product.
The new AVM-GSL status, allows the product to be sold on the shelves instead of being a behind the counter product sold at stores with SQP status, Beaphar were the first manufacturer to make a combination flea treatment available for all retailers to sell in this way.
The FIPROtec combo, containing fipronil, which kills adult fleas, and the Insect Growth Regulator (IGR) S-methoprene. S-methoprene interrupts the flea lifecycle, preventing flea eggs and flea larvae from developing.
Alongside in-store activity, Beaphar will also be increasing awareness and education around fleas online. Throughout the flea season, blogs and flea facts will be shared across their social media platforms.
Dr Sue Huggett, business manager, Beaphar UK said: ‘We were the first manufacturer to take a combination flea spot-on over-the-counter, bringing increased sales opportunities to all retailers and giving access to a more convenient form of flea treatment to all pet owners. We now want to help retailers further. With our consumer campaign, which includes eye-catching point-of-sale, advertising and online activity, we can help them to build their customer base and make the most out of this year’s flea season.
“While Beaphar FIPROtec combo is an ideal product for busy families, no two households are the same. Different families will have different lifestyles and different flea control requirements. With this in mind, we have created additional materials to promote our original Beaphar FIPROtec Spot-On products, as well as the newest addition to the Beaphar FIPROtec Range, Beaphar FIPROtec Spray.”